BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14670645)

  • 1. Differential effects of progestins on breast tissue enzymes.
    Pasqualini JR
    Maturitas; 2003 Dec; 46 Suppl 1():S45-54. PubMed ID: 14670645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestins and breast cancer.
    Pasqualini JR
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective estrogen enzyme modulator (SEEM) in breast cancer.
    Chetrite GS; Pasqualini JR
    J Steroid Biochem Mol Biol; 2001; 76(1-5):95-104. PubMed ID: 11384867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
    Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
    Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer and steroid metabolizing enzymes: the role of progestogens.
    Pasqualini JR
    Maturitas; 2009 Dec; 65 Suppl 1():S17-21. PubMed ID: 19962254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects of progestins in breast cancer.
    Pasqualini JR; Ebert C; Chetrite GS
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():44-52. PubMed ID: 12227886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
    Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SEEM: selective estrogen enzyme modulators in breast cancer.
    Pasqualini JR; Ebert C; Chetrite GS
    Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():1-8. PubMed ID: 10862262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrone sulfatase versus estrone sulfotransferase in human breast cancer: potential clinical applications.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 1999; 69(1-6):287-92. PubMed ID: 10419004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effects of progestins in breast cancer.
    Pasqualini JR; Ebert C
    Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():11-9. PubMed ID: 12227897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestins and breast cancer.
    Pasqualini JR; Paris J; Sitruk-Ware R; Chetrite G; Botella J
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):225-35. PubMed ID: 9699877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
    Pasqualini JR
    Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells.
    Chetrite G; Paris J; Botella J; Pasqualini JR
    J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):525-31. PubMed ID: 8918978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Actions of a 19-norprogesterone derivative on mammary gland: nomegestrol acetate].
    André G
    J Gynecol Obstet Biol Reprod (Paris); 2005 Feb; 34(1 Pt 1):69-84. PubMed ID: 15767920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
    Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.